Thursday, October 12, 2023
8 am PT, 11 am ET, 17:00 CET
View the recording
A fundamental research question continues to resonate today: How can we proactively develop countermeasures against future viral outbreaks?
Join leaders in industry and academia for this important, one-hour discussion on the latest technologies, experiences, and strategies within the study and development of therapeutics against emerging viruses, such as influenza, SARS-CoV-2, and dengue. We’ll explore:
- The use of pseudovirus Reporter Virus Particles (RVPs) in place of live viruses
- How to drive the safe study of new virus variants and mutations of interest
- Why innovative research tools play a critical role in the development of vaccines and treatments for a range of biological threats
- Real-world case studies from top industry organizations
- And more
